Pharma manufacturing success depends on enhancing the most essential KPIs such as quality, yield, and productivity to accelerate time-to-market (eQYPt) and optimize operational efficiency.
As the discovery of new pharmaceuticals continues to soar, a tremendous opportunity exists in accelerating the transition from biology to process manufacturing of new medical modalities.